相关实验视频

Updated: Jan 8, 2026

Zinc-finger Nuclease Enhanced Gene Targeting in Human Embryonic Stem Cells

Zinc-finger Nuclease Enhanced Gene Targeting in Human Embryonic Stem Cells

Published on: August 23, 2014

基因替代疗法用于发育中的神经系统中Piga GPI基因缺乏症

Jennifer L Watts¹, Shibi Likhite², Yoshiko Murakami³

¹Steve and Cindy Rasmussen Institute for Genomic Medicine, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH., 43215, USA.

bioRxiv : the preprint server for biology

|December 19, 2025

概括

使用AAV9-hPIGA的基因治疗成功地治疗了小鼠PIGA相关的大脑异常. 这种方法恢复了生存率和神经功能,为PIGA患者提供了希望.

科学领域:

神经科学是一个神经科学.
遗传学是一个遗传学.
生物化学生物化学

背景情况:

葡萄糖酸酸 (GPI) 是150多种蛋白质的关键翻译后修改.
GPI生物合成酶PIGA的致病变体会导致人类严重的脑异常和死亡.
对PIGA患者的现有治疗方法是息的,突出显示了对新型治疗策略的需求.

研究的目的:

在PIGA缺陷的小鼠模型中评估AAV9-介导PIGA基因替代疗法的疗效.
评估基因治疗对PIGA突变小鼠生存,大脑结构和神经功能的影响.

主要方法:

在胚胎小鼠大脑中遗传删除Piga,以模拟人类PIGA变体.
在生命的第一天,AAV9-hPIGA的单次脑内静脉注射.
质谱测量量治疗和未治疗小鼠的GPI定蛋白质.

主要成果:

在PIGA突变小鼠中,AAV9-hPIGA治疗显著改善了生存率.
基因疗法纠正了结构性大脑形和神经障碍.
质谱测量证实了治疗后GPI定蛋白质水平的恢复.

结论:

以AAV9为媒介的PIGA基因替代是一种对PIGA相关疾病的有前途的治疗策略.
这种方法为改善受影响个体的大脑发育和功能提供了潜在的干预措施.
这项研究促进了对大脑发育过程中GPI定蛋白调节的理解.

更多相关视频

Induction of Protein Deletion Through In Utero Electroporation to Define Deficits in Neuronal Migration in Transgenic Models

Induction of Protein Deletion Through In Utero Electroporation to Define Deficits in Neuronal Migration in Transgenic Models

Published on: January 12, 2015

Isolation, Culture, and Genetic Engineering of Mammalian Primary Pigment Epithelial Cells for Non-Viral Gene Therapy

Isolation, Culture, and Genetic Engineering of Mammalian Primary Pigment Epithelial Cells for Non-Viral Gene Therapy

Published on: February 26, 2021

相关概念视频

In-vitro Mutagenesis

In-vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.